CHMP5 and COVID-19: In addition, previous studies have pointed out that the androgen receptor (AR) signal controls the expression of TMPRSS2 [76], and TMPRSS2 is necessary for the SARS-CoV-2 spike protein to infect the human body, so androgen receptor inhibitors are used and have therapeutic potential for COVID-19.